‘Covishield’ vaccine volunteer sues Serum Institute of India, Oxford Group over ‘adverse reaction’

A 40-year-old volunteer for ‘Covishield’, the candidate vaccine being tested by the Pune-based Serum Institute of India (SII), has sued the company for ₹5 crore, alleging that the vaccine triggered an adverse reaction, which includes neurological impairment and an inability to get back to the life before being inoculated. He has also demanded, via a legal notice sent to the SII, AstraZeneca and the Oxford Vaccine Group, that the vaccine trial, which is now being tested on 1,600 volunteers in India, be immediately halted. The person’s discharge summary says he was “discharged at request” and was recovering from “acute encephalopathy”. He also had Vitamin B12 and Vitamin D deficiency, and had a probable “connective tissue disorder”. Dr. S.R. Ramakrishnan, who was the lead investigator for the Chennai arm of the trial and had treated the patient, told The Hindu that the “subject was now alright” but directed further questions to the Serum Institute spokesperson. “He recovered very…